
    
      Women will be randomly divided into two groups; one will be subjected to anticoagulant
      therapy by Enoxaparin throughout pregnancy and the other will be subjected to anticoagulant
      therapy by Enoxaparin in the first trimester then Warfarin after the first trimester until
      termination of pregnancy.
    
  